Skip to main content

$6.600 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
20 June 2025 at 1:26pm
Register to track MDC and receive email alerts.
Subject
MDC Ann: Medlab Update to Shareholders

MDC Ann: Response to ASX Query

MDC Ann: Medlab Update to Shareholders

MDC Ann: Final Director's Interest Notice

MDC Ann: Initial Director's Interest Notice

MDC Ann: Company Status and Board Composition Updates

MDC Ann: Appointment of External Consultants to Medlab

MDC Ann: Suspension from Official Quotation

MDC Ann: Trading Halt

MDC Ann: Aust ODC Approves NanaDol Export for UK Use

MDC Ann: Appendix 4C Administrative Clarification

MDC Ann: UK Home Office Grants UK Import Certificate for NanaBis

MDC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

MDC Ann: Medlab Announces Interim Readout of RWE Medcare Study

MDC Ann: Medlab Files Registration Statement for Proposed US IPO

MDC Ann: NASDAQ Progression - Medlab Clears SEC Comments

MDC Ann: First Tranche IP Royalty Payment from Pharmacare

MDC Ann: Medlab receives UK Import Permission from MHRA for NanaBis

MDC Ann: Jefferies HealthCare Conference NanoCelle Presentation

MDC Ann: NanoCelle Nasal RNA (Nucleid Acid) Program Update

MDC Ann: Medlab Presents NanoCelle at Jefferies Conference London

MDC Ann: Notification of cessation of securities - MDC

MDC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

MDC Ann: Grant of waiver of Listing Rule 14.7

MDC Ann: MDC 2022 AGM Voting Results

MDC Ann: Medlab AGM Presentation

MDC Ann: Medlab Progresses Nasdaq Dual Listing

MDC Ann: Medlab Received 2022 R&D Claim

MDC Ann: NanaBis and NanoCBD Clinical Development Update

MDC Ann: Final Director's Interest Notice

MDC Ann: MDC Director Resignation Announcement

MDC Ann: Corporate Governance Statement 2022

MDC Ann: Appendix 4G

MDC Ann: Annual Report to shareholders

MDC Ann: Preliminary Final Report

MDC Ann: MDC Notice of Annual General Meeting/Proxy Form

MDC Ann: Biotech Investors' Conference Presentation

MDC Ann: Depression European Patent Accepted, Proceeding to Grant

MDC Ann: Initial Director's Interest Notice

MDC Ann: Leading Healthcare Executive joins Medlab Board

MDC Ann: Share Consolidation update & despatch of holding statements

MDC Ann: UNSW Medlab Laboratory Collaboration Additional Information

MDC Ann: Medlab enters Laboratory Collaboration with UNSW, Sydney

MDC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

MDC Ann: Results of MDC July 2022 EGM

MDC Ann: Change of Director's Interest Notice

MDC Ann: Change of Director's Interest Notice

MDC Ann: Consolidation/Split - MDC

MDC Ann: EGM Notice of Meeting to Approve Dual Listing to Nasdaq

MDC Ann: Trading Halt

Register to track MDC and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX